| Date Filed | Type | Description |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 05/17/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/17/2023 |
4
| VERNON W ANTHONY (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/17/2023 |
4
| FALBERG KATHRYN E (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/17/2023 |
4
| BLICKENSTAFF KIM D (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/17/2023 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/04/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/16/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/15/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/15/2023 |
8-K
| Quarterly results |
| 03/02/2023 |
4
| Markel Stacy (Chief People Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.94, valued at
$970k
|
|
| 03/02/2023 |
4
| Hung David (President and CEO) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Disposed of 368,408 shares
@ $0
Granted 2,500,000 options to buy
@ $1.94, valued at
$4.9M
|
|
| 03/02/2023 |
4
| Hanley David C. (Chief Technical Operations) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.94, valued at
$970k
|
|
| 03/02/2023 |
4
| Fox Jennifer A. (CFO) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 600,000 options to buy
@ $1.94, valued at
$1.2M
|
|
| 03/02/2023 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.94, valued at
$776k
|
|
| 03/02/2023 |
4
| Liu Dongfang (Chief Medical Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.94, valued at
$970k
|
|
| 03/02/2023 |
4
| Hattersley Gary (Chief Scientific Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.94, valued at
$970k
|
|
| 03/02/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 12.1% stake in NUVATION BIO INC |
| 12/23/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/03/2022 |
8-K
| Quarterly results |
| 08/31/2022 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 252,000 options to buy
@ $2.93, valued at
$738.4k
|
|
| 08/31/2022 |
4
| Markel Stacy (Chief People Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 450,000 options to buy
@ $2.93, valued at
$1.3M
|
|
| 08/31/2022 |
4
| Liu Dongfang (Chief Medical Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 315,000 options to buy
@ $2.93, valued at
$923k
|
|
| 08/31/2022 |
4
| Hattersley Gary (Chief Scientific Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 400,000 options to buy
@ $2.93, valued at
$1.2M
|
|
|